Localized Attention On A Global Scale: A Phase III Study In Early Alzheimer’s

For a clinical trial conducted on a global scale, regional variability in regulatory considerations and clinical practice creates significant complexity. If not aligned appropriately, these differences can compromise the integrity of study data and threaten the ultimate success of the program. In a new case study, entitled Localized Attention on a Global Scale, Worldwide Clinical Trials outlines how our team successfully managed a Phase III study in early Alzheimer’s at 250 investigative sites across 14 countries.

Your form has been successfully submitted! Click the button below to access.